drugset / Trial / NCT07208591
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy, safety and tolerability of STSA-1002 injection in patients with acute respiratory distress syndrome
Timeline
- Start
- 2025-10-31
- Primary completion
- 2026-07
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GREZIPRUBART | Monoclonal antibody | — | Intravenous |